House Rx Raises $55M to Scale In-Clinic Specialty Pharmacy Model
Summary
House Rx raised $55 million in Series B equity and debt to expand its in-clinic specialty pharmacy model. The company uses software, AI workflows, and pharmacist-physician collaboration to help clinics dispense specialty medications directly to patients. It has partnered with more than 1,000 providers across 80 clinic sites and now processes about $1.5 billion in specialty prescriptions each year. The new capital will support rapid scaling of its platform and the rollout of additional AI capabilities.
Funding
Amount
$55.0M
Total raised
Date
November 12, 2025
Announcement date
Investors
New Enterprise Associates, SVB Capital, First Round Capital, LRVHealth
Lead investors
Company
houserx.com
Funded company
Classifications
industries
HealthTech
applications
Human Resources
AskAI Classifications
Labels
Healthcare SaaS
Pharmacy Management Software
Workflow Automation Software
Linked Companies
House Rx
$5M to $10M